Welcome to...The UCLA Endocrine Surgical Unit
 

Schedule an Appointment
Endocrine Home
About Us
Our Expert Team
Our Services
First Visit for Patients
Patient Education
Scar Gallery
For Referring Physicians
Distance Surgery Program
International Patients
Insurance Questions
Map-Directions-Parking
Contact Us
Patient Experiences
Endocrine Resources
Site Map

UCLA Health System


Schedule an Appointment


Parathyroid News Feeds

Worldwide News: View Endocrine News | View Parathyroid News


Fri, 05 Dec 2014 21:25:44 GMT
• Higher Aldosterone Linked to Increased Parathyroid Hormone Levels - Endocrinology Advisor

Higher Aldosterone Linked to Increased Parathyroid Hormone Levels
Endocrinology Advisor
Both aldosterone and parathyroid hormone (PTH) play a role in the development of cardiovascular and skeletal disease, with research suggesting a relationship between the two. These findings have raised questions about whether this relationship can be ...


Thu, 04 Dec 2014 11:26:28 GMT
• Lilly and Zosano to collaborate on osteoporosis drug development - Zenopa

Lilly and Zosano to collaborate on osteoporosis drug development
Zenopa
The companies will work together to develop and commercialise ZP-PTH, a proprietary formulation of parathyroid hormone 1-34 that uses Zosano's microneedle patch system for the treatment of osteoporosis patients. Zosano has granted Lilly an exclusive ...

and more »

Tue, 02 Dec 2014 14:37:15 GMT
• NPS Pharmaceuticals (NPSP) Reports EMA Review, Validation of Natpar MAA - StreetInsider.com (subscription)

NPS Pharmaceuticals (NPSP) Reports EMA Review, Validation of Natpar MAA
StreetInsider.com (subscription)
NPS Pharmaceuticals (NASDAQ: NPSP) announced that the European Medicines Agency (EMA) has validated and initiated its review of the company's marketing authorization application (MAA) for Natpar (parathyroid hormone (rDNA)) for the treatment of ...

and more »

Thu, 06 Nov 2014 20:45:46 GMT
• Vitamin D Supplements for Hypocalcemia in Thyroid Cancer - Medscape

Vitamin D Supplements for Hypocalcemia in Thyroid Cancer
Medscape
Low postoperative serum parathyroid-hormone level (less than 15 pg/mL) was the strongest predictor of hypocalcemia based on the need for IV calcium infusion (P < .001). But preoperative vitamin D deficiency was also a predictive factor for symptomatic ...


Thu, 23 Oct 2014 20:35:38 GMT
• PDUFA Action Date for NatparaŽ BLA Extended Three Months to January 24 ... - MarketWatch

PDUFA Action Date for NatparaŽ BLA Extended Three Months to January 24 ...
MarketWatch
Hypoparathyroidism is a rare endocrine disorder affecting only approximately 50,000 people in the U.S. in which the parathyroid glands fail to produce sufficient amounts of PTH or where the hormone lacks biologic activity. PTH plays a central role in a variety ...

and more »


Worldwide "Parathyroid" News Courtesy of Google News